Cas:933690-44-9 2-(2-Azabicyclo[2.2.1]heptan-2-yl)acetic acid manufacturer & supplier

Chemical Name:2-(2-Azabicyclo[2.2.1]heptan-2-yl)acetic acid

CAS.NO:933690-44-9

Synonyms:2-Azabicyclo[2.2.1]hept-2-ylacetic acid;2-Azabicyclo[2.2.1]heptane-2-acetic acid;2-(2-azabicyclo[2.2.1]hept-2-yl)acetic acid

Molecular Formula:C₈H₁₃NO₂

Molecular Weight:155.194

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:275.0±23.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.538

PSA:40.54000

Exact Mass:155.094635

LogP:0.82

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-Azabicyclo[2.2.1]hept-2-ylacetic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(2-azabicyclo[2.2.1]hept-2-yl)acetic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(2-azabicyclo[2.2.1]hept-2-yl)acetic acid Use and application,2-(2-azabicyclo[2.2.1]hept-2-yl)acetic acid technical grade,usp/ep/jp grade.

Related News: Huahai started with the development of characteristic APIs and pharmaceutical intermediates. At the same time, using the international cooperation platform and the opportunity of the expiry of patent protection of major international original research drugs, Huahai has extended the industrial chain to downstream high value-added preparations, and formed intermediates and materials The complete industrial chain of medicine and preparation integration. 2-(2-Azabicyclo[2.2.1]heptan-2-yl)acetic acid manufacturer Targets within the tumor microenvironment may include both plasma membrane proteins as well as proteins typically secreted into the extracellular space. 2-(2-Azabicyclo[2.2.1]heptan-2-yl)acetic acid supplier The company-backed investigation was based on interviews with more than 100 people, the May 20 memo to Lilly employees said. However, the memo did not respond to all concerns employees raised in their April complaint, which Reuters reviewed. 2-(2-Azabicyclo[2.2.1]heptan-2-yl)acetic acid vendor Alira is one of many in the CRO space to ink deals in recent months. Altasciences acquired preclinical CRO Calvert Laboratories in May, weeks after itself being bought out by Novo Holdings, and a few months after buying early-stage CRO WCCT Global. 2-(2-Azabicyclo[2.2.1]heptan-2-yl)acetic acid factory The researchers found that compared with those with cancer, the prevalence of FT was higher among those with ASCVD (54 versus 41 percent). In adjusted analyses, when studying individual components of FT, those with ASCVD had increased odds of any difficulty paying medical bills, inability to pay bills, cost-related medication nonadherence, food insecurity, and foregone/delayed care due to cost (odds ratios, 1.22, 1.25, 1.28, 1.39, and 1.17, respectively).